Clinical Trials Logo

Clinical Trial Summary

The level of fibre consumption in France is lower than the national and international recommendations (mean 18.8 g/d for men, 16.4 g/d for women (INCA 2007 Study) instead of 30g/d recommended). Fibre have beneficial effects on health and interact with the intestinal microbiota diversity: a diet fortified with different structure fibres increase of 25 % the dysbiotic intestinal microbiota in obese patient (Cotillard et al, Dietary intervention impact on gut microbial gene richness. Nature, August 2013). The study aim is to evaluate the impact of daily consumption of bread (150 g ) enriched with a mixture of fibres of different structure (15g) during two months on the intestinal microbiota composition in metabolic risk subjects (abdominal overweight or obese) and also, to assess the correlation between the microbiota change and their metabolic profile improvement.It is a mono centric study with a centre in LYON (Centre de Recherche en Nutrition Humaine Rhône-Alpes)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03875898
Study type Interventional
Source Bridor
Contact
Status Completed
Phase N/A
Start date June 8, 2017
Completion date November 26, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05242211 - Cardio-Pulmonary Exercise Testing in Healthy Population N/A
Active, not recruiting NCT05191160 - The Soy Treatment Evaluation for Metabolic Health (STEM) Trial N/A
Completed NCT03322514 - Colonic Propionate, Appetite, and Weight Loss N/A
Completed NCT06411483 - Determining the Physiological Mechanisms Behind the ObeEnd Device on Factors Regulating Appetite N/A
Completed NCT03861754 - Effects of Physical Activity on Weight Loss and Weight Maintenance in Obese Adults - Three Year Follow-up Study N/A
Not yet recruiting NCT03772067 - Influence of Dairy Protein Breakfast on Glycemia, Weight Loss and Clock Genes in T2D N/A